Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers-Reference-Cited by-同舟云学术

Renal Cell Carcinoma (RCC) Tumors Display Large Expansion of Double Positive (DP) CD4+CD8+ T Cells With Expression of Exhaustion Markers

Published:2018-11-26 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Menard Laurence C.,Fischer Paul,Kakrecha Bijal,Linsley Peter S.,Wambre Erik,Liu Maochang C.,Rust Blake J.,Lee Deborah,Penhallow Becky,Manjarrez Orduno Nataly,Nadler Steven G.

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference51 articles.

1. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med.,2015

2. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med.,2015

3. Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial;Hodi;Lancet Oncol.,2016

4. Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial;Hui;Ann Oncol.,2017

5. Tumor mutational burden and response rate to PD-1 inhibition;Yarchoan;N Engl J Med.,2017

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome;npj Precision Oncology;2024-06-19

2. Abstract 3843: Role of CD4/CD8 double positive T cells in modulating response to anti-PD-1 treatment in renal cell carcinoma;Cancer Research;2024-03-22

3. Kidney double positive T cells have distinct characteristics in normal and diseased kidneys;Scientific Reports;2024-02-23

4. Single-cell profiling of the microenvironment in human bone metastatic renal cell carcinoma;Communications Biology;2024-01-12

5. Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands;Frontiers in Immunology;2023-09-19